Skip to content

Exagen Inc. XGN Common Stock

Common Stock at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
265M0.0%
Quest Diagnostics logo
Quest DiagnosticsDGX
$2M0.0%
Vor Biopharma logo
Vor BiopharmaVOR
$19K+46.2%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
200M0.0%
CareDx logo
CareDxCDNA
100M0.0%
Revvity logo
RevvityRVTY
300M0.0%

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s common stock?
Exagen Inc. (XGN) reported common stock of 200M in Q1 2026.
How has Exagen Inc.'s common stock changed year-over-year?
Exagen Inc.'s common stock decreased by 0.0% year-over-year, from 200M to 200M.
What is the long-term trend for Exagen Inc.'s common stock?
Over 5 years (2020 to 2025), Exagen Inc.'s common stock has grown at a 0.0% compound annual growth rate (CAGR), from 200M to 200M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).